| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
P2RY13 |
P2RY13, GPR86, FKSG77, GPR94: P2Y purinoceptor 13 |
0.347 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
P2RY14 |
P2RY14, GPR105, KIAA0001: P2Y purinoceptor 14 |
0.347 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
CXCR3 |
CXCR3, GPR9: C-X-C chemokine receptor type 3 |
0.347 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
CCR7 |
CCR7, CMKBR7, EBI1, EVI1: C-C chemokine receptor type 7 precursor |
0.347 |
Evidence |
|
| SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
TPSG1 |
TPSG1, PRSS31, TMT: Tryptase gamma precursor |
0.347 |
Evidence |
|
| SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
MASP1 |
MASP1, CRARF, CRARF1, PRSS5: Complement-activating component of Ra-reactive fact |
0.347 |
Evidence |
|
| HCK |
IPI00029769 |
FYN |
IPI00640091 |
0.347 |
Evidence |
|
| P4HB |
P4HB, ERBA2L, PDI, PDIA1, PO4DB: Protein disulfide-isomerase precursor |
ERO1L |
ERO1L, UNQ434/PRO865: ERO1-like protein alpha precursor |
0.347 |
Evidence |
|
| PROS1 |
PROS1, PROS: Vitamin K-dependent protein S precursor |
AEBP1 |
CDNA FLJ45634 fis, clone CHONS2002829, moderately similar to Homo sapiens adipoc |
0.347 |
Evidence |
|
| HLA-DOA |
HLA-DOA, HLA-DNA, HLA-DZA: HLA class II histocompatibility antigen, DO alpha cha |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
0.347 |
Evidence |
|
| HLA-DOA |
HLA-DOA, HLA-DNA, HLA-DZA: HLA class II histocompatibility antigen, DO alpha cha |
HLA-DRB5 |
HLA-DRB3: HLA class II histocompatibility antigen, DRB3-1 beta chain precursor |
0.347 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
PRSS8 |
PRSS8: Prostasin precursor |
0.347 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
TPSG1 |
TPSG1, PRSS31, TMT: Tryptase gamma precursor |
0.347 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
MASP1 |
MASP1, CRARF, CRARF1, PRSS5: Complement-activating component of Ra-reactive fact |
0.347 |
Evidence |
|
| CYP11A1 |
CYP11A1, CYP11A: Cytochrome P450 11A1, mitochondrial precursor |
CYB5R1 |
CYB5R1, NQO3A2, UNQ3049/PRO9865: NADH-cytochrome b5 reductase 1 |
0.347 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
CD1C |
CD1C: T-cell surface glycoprotein CD1c precursor |
0.347 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
0.347 |
Evidence |
|
| MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
TFEC |
TFEC, Tfec, tcag7.74: TFEC isoform |
0.347 |
Evidence |
|
| MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
MNT |
MNT, ROX: Max-binding protein MNT |
0.347 |
Evidence |
|
| MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
TCF12 |
TCF12, HEB, HTF4: Transcription factor 12 |
0.347 |
Evidence |
|
| CSTB |
CSTB, CST6, STFB: Cystatin-B |
CAPN2 |
CAPN2, CANPL2: Calpain-2 catalytic subunit precursor |
0.347 |
Evidence |
|
| OPN1MW |
OPN1MW, GCP: Green-sensitive opsin |
GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
0.347 |
Evidence |
|
| HLA-DQB1 |
HLA-DQB, HLA-DRB1: HLA class II histocompatibility antigen, DQ(1) beta chain pre |
HLA-DOA |
HLA-DOA, HLA-DNA, HLA-DZA: HLA class II histocompatibility antigen, DO alpha cha |
0.347 |
Evidence |
|
| HLA-DQA1 |
HLA-DQA1: HLA class II histocompatibility antigen, DQ(5) alpha chain precursor |
HLA-DOA |
HLA-DOA, HLA-DNA, HLA-DZA: HLA class II histocompatibility antigen, DO alpha cha |
0.347 |
Evidence |
|
| HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
CD1C |
CD1C: T-cell surface glycoprotein CD1c precursor |
0.347 |
Evidence |
|
- 
-